WallStreetZenWallStreetZen

NASDAQ: EQ
Equillium Inc Stock Ownership - Who owns Equillium?

Insider buying vs selling

Have Equillium Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Jason A. KeyesChief Financial Officer2022-12-094,444$1.19
$5.29kBuy
Joel RothmanChief Development Officer2022-12-093,821$1.19
$4.55kBuy

1 of 1

EQ insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when EQ insiders and whales buy or sell their stock.

EQ Shareholders

What type of owners hold Equillium Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Decheng Capital Management Iii Cayman LLC12.66%4,447,308$2.70MInstitution
Daniel Bradbury10.57%3,711,995$2.25MInsider
Bruce D. Steel10.57%3,711,995$2.25MInsider
Decheng Capital Global Life Sciences Fund Iv LP9.36%3,285,710$1.99MInsider
Sa Biocon6.60%2,316,134$1.41MInsider
Stephen Connelly2.83%993,000$602.75kInsider
Franklin Resources Inc2.55%895,000$543.27kInstitution
Jpmorgan Chase Co2.49%873,609$530.28kInstitution
Vanguard Group Inc2.38%836,930$508.02kInstitution
Cota Capital Management LLC1.60%562,278$341.30kInstitution

1 of 3

EQ vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
EQ25.97%40.75%Net Buying
TFFP19.52%18.07%Net Buying
APTO9.80%90.20%Net BuyingNet Buying
LSTA0.78%99.22%Net Selling
FBRX45.96%21.83%Net BuyingNet Selling

Equillium Stock Ownership FAQ

Who owns Equillium?

Equillium (NASDAQ: EQ) is owned by 25.97% institutional shareholders, 40.75% Equillium insiders, and 33.28% retail investors. Daniel Bradbury is the largest individual Equillium shareholder, owning 3.71M shares representing 10.57% of the company. Daniel Bradbury's Equillium shares are currently valued at $2.19M.

If you're new to stock investing, here's how to buy Equillium stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.